Stevels Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 06-07-2024
- Paid Up Capital ₹ 4.00 M
as on 06-07-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.55 Cr
as on 06-07-2024
- Revenue 77.90%
(FY 2017)
- Profit 52.16%
(FY 2017)
- Ebitda 334.42%
(FY 2017)
- Net Worth -342.09%
(FY 2017)
- Total Assets 10.19%
(FY 2017)
About Stevels Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.55 Cr.
Harvinder Sachar, Inderjit Chhibber, and Dinesh Sharma serve as directors at the Company.
- CIN/LLPIN
U24230CH2004PLC027156
- Company No.
027156
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 May 2004
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Stevels Pharma Limited offer?
Stevels Pharma Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Arthritic Drugs, Muscle Relaxant.
Who are the key members and board of directors at Stevels Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harvinder Sachar  | Director | 27-May-2004 | Current |
| Inderjit Chhibber | Director | 27-May-2004 | Current |
| Dinesh Sharma | Director | 10-Aug-2015 | Current |
Financial Performance of Stevels Pharma.
Stevels Pharma Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 77.9% increase. The company also saw a substantial improvement in profitability, with a 52.16% increase in profit. The company's net worth observed a substantial decline by a decrease of 342.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stevels Pharma?
In 2017, Stevels Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vishvas Publications Private LimitedActive 29 years 7 monthsHarvinder Sachar and Inderjit Chhibber are mutual person
Taureans Print Pack Private LimitedActive 15 years 7 monthsHarvinder Sachar and Inderjit Chhibber are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 22 Jan 2014 | ₹9.53 M | Open |
Bank Of Baroda Creation Date: 19 Mar 2009 | ₹0.50 M | Open |
Bank Of Baroda Creation Date: 15 Nov 2007 | ₹1.15 M | Open |
How Many Employees Work at Stevels Pharma?
Unlock and access historical data on people associated with Stevels Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stevels Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stevels Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
